Search results
Results from the Health.Zone Content Network
The Peace and Security Council ( PSC) is the organ of the African Union in charge of enforcing union decisions. It is patterned somewhat after the United Nations Security Council. The PSC is also the main pillar of the African Peace and Security Architecture (APSA), and works with other pillars of the APSA in order to promote "peace, security ...
PSC develops slowly. You may have it for years before you notice any symptoms. Some of the signs are: Fatigue. Itchy skin. Yellowish skin and eyes caused by a condition called jaundice. As PSC ...
The Common European Framework of Reference for Languages: Learning, Teaching, Assessment, [1] abbreviated in English as CEFR, CEF, or CEFRL, is a guideline used to describe achievements of learners of foreign languages across Europe and, increasingly, in other countries. The CEFR is also intended to make it easier for educational institutions ...
Psoriasis is a skin disorder that causes skin cells to multiply up to 10 times faster than normal. This makes the skin build up into bumpy patches. On lighter skin, the patches can be red with ...
An intelligent tutoring system ( ITS) is a computer system that imitates human tutors and aims to provide immediate and customized instruction or feedback to learners, [1] usually without requiring intervention from a human teacher. [2] ITSs have the common goal of enabling learning in a meaningful and effective manner by using a variety of ...
Psychiatry, Clinical psychology. Adult Attention Deficit Hyperactivity Disorder is the persistence of attention deficit hyperactivity disorder (ADHD) in adults. It is a neurodevelopmental disorder, meaning symptoms must have been present in childhood except for when ADHD occurs after a traumatic brain injury. [1] [2] [3] Specifically, multiple ...
160 or higher; 190 is considered very high. 200 or higher; 500 is considered very high. Low. n/a. less than 40 for men and less than 50 for women. n/a. n/a. Guidelines are similar for males and ...
Side effects were reported in 69 percent of people taking evolocumab in clinical trials, including: swelling or rash at the injection site. limb pain. fatigue. Less than 1 percent of people in the ...